Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,365 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Recruiting

Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN).

NCT05977907

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Recruiting

SMP-3124LP in Adults With Advanced Solid Tumors

NCT06526819

Conditions
Anus Diseases, Anus Neoplasms, Breast Diseases, +30 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
  • Northwestern Medicine Cancer Center Chicago, Illinois, United States
  • Ohio State University Columbus, Ohio, United States
View Trial Details
Recruiting

A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

NCT05544136

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +8 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

NCT07063212

Conditions
Carcinoma, Carcinoma, Squamous Cell, HPV Positive Oropharyngeal Squamous Cell Carcinoma, +29 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

NCT06305962

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +46 more
Locations
  • Nepean Hospital Kingswood, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • Gold Coast University Hospital Southport, Queensland, Australia
  • Cancer Research SA (CRSA) Adelaide, South Australia, Australia
View Trial Details

Related conditions